Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Intracranial Aneurysm Market by Type (Surgical Clipping, Endovascular Coiling, Flow Diverters, Others), by End User (Hospitals, Clinics, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

A10205

Pages: 243

Charts: 56

Tables: 118

Intracranial Aneurysm Market Research, 2031

The global Intracranial Aneurysm Market Size was valued at $1.3 billion in 2021, and is projected to reach $2.7 billion by 2031, growing at a CAGR of 7.6% from 2022 to 2031. A cerebral or intracranial aneurysm is an abnormal focal dilation of an artery in the brain that results from a weakening of inner muscular layer (the intima) of a blood vessel wall. The vessel develops a "blister-like" dilation that can become thin and rupture without warning, which results in bleeding into the space around brain and is called a subarachnoid hemorrhage (SAH). This kind of hemorrhage can lead to a stroke, coma, and/or death. Aneurysms range in size, from small about 1/8 inch to nearly one inch. Aneurysms larger than one inch are called giant aneurysms, pose a particularly high risk, and are difficult to treat. The exact mechanism by which cerebral aneurysms develop, grow, and rupture is unknown. Berry or saccular aneurysm are the most frequently observed types of aneurysms. Almost 90% of the total aneurysm patients suffer from these types of aneurysms.

[COVIDIMPACTSTATEMENT]

Key factors that drive the Intracranial Aneurysm Market Growth are increase in the incidences of brain aneurysms, increase in geriatric population, increase in adoption of technologically advanced intracranial aneurysm products such as endovascular coils, surgical clipping and flow diverters. For instance, according to the report published by the Brain Aneurysm Foundation, it has been estimated that 6.5 million people in the U.S. have an unruptured brain aneurysm, i.e., 1 in 50 people. The annual rate of rupture is approximately 8 – 10 per 100,000 people and around 30,000 people in the U.S. suffer a brain aneurysm rupture each year.

Moreover, it has been reported that women are more likely than men to have a brain aneurysm (3:2 ratio) particularly those over the age of 55, have a higher risk of brain aneurysm rupture than men (about 1.5 times the risk). There are almost 500,000 deaths worldwide each year caused by brain aneurysms, and half the victims are younger than 50. The reason behind rise in prevalence of cerebrovascular disease are hypertension, cigarette smoking, and unhealthy lifestyle which leads to injury or trauma to blood vessels causing brain aneurysm. Furthermore, increase in demand of minimally invasive surgeries owing to reduced risk and trauma associated with the procedures propels the growth of the market. Numerous key players are continuously investing in R&D for the launch of innovative minimally invasive endovascular coiling instruments that are anticipated to fuel the Intracranial Aneurysm Market Size in upcoming years.

However, high cost of disease management and complications occurring during the craniotomy surgery are major barriers for growth of the market. Emerging economies such as India, China, Mexico, and Brazil are anticipated to create new opportunities during the forecast period. For instance, increasing medical tourism in India owing to relatively low cost of intracranial surgery in comparison with other developed countries such as the U.S. is expected to provide lucrative intracranial aneurysm market opportunity for the market growth.

The intracranial aneurysm market is segmented on the basis of type, end user and region. By type the market is segmented into surgical clipping, endovascular coiling, flow diverters and others. By end user it is segmented into hospitals, clinics and others. Region-wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Type Segment review

By type, the intracranial aneurysm market is segmented into surgical clipping, endovascular coiling, flow diverters and others. In 2021, the endovascular coiling segment accounted for the largest share of the market. The dominance of this segment is attributed to rise in number of patients suffering from cerebrovascular disease and increase in  adoption of minimally invasive surgical procedures to treat aneurysm.

The flow diverters segment is anticipated to grow at a significant rate during the forecast period. Owing to latest technological developments, increasing cases of cerebrovascular disease and the surge in adoption of technologically advanced flow diverters or embolization device.

[TYPEGRAPH]

End User Segment Review

By end user, the Intracranial Aneurysm Industry is segmented into hospitals, clinics and others. The hospitals segment exhibited the highest Intracranial Aneurysm Market Share in 2021, and is anticipated to lead during the forecast period, owing to increase in number of patients visiting the hospital for intracranial surgery and the use of technologically advanced surgical equipment in operation theaters and intensive care units for brain aneurysm.

The clinics segment is expected to witness considerable Intracranial Aneurysm Industry growth during the forecast period, owing to rise in number of people suffering from hypertension, surge in demand of minimally invasive surgical procedures and increase in number of patients visiting clinics for cerebrovascular surgery due to availability of advanced surgical devices.

[ENDUSERGRAPH]

Region Segment Review

Region wise, the intracranial aneurysm market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for most of  intracranial aneurysm market share in 2021 and is anticipated to remain dominant during the forecast period. Owing to  high adoption rate of technologically advanced surgical devices for intracranial aneurysm, increase in the healthcare expenditure and presence of major key players in the country and the strategies they adopt for the development of intracranial devices such as endovascular coiling, surgical clipping, flow diverters and various others.

Asia-Pacific is expected to register the fastest CAGR during the forecast period. This is due to the growing demand for minimal invasive therapies, healthcare reforms, highly populated countries along with high geriatric population and high prevalence rate of hypertension.in developing countries China, India and among others

[REGIONGRAPH]

The key players that operate in the intracranial aneurysm market are B. Braun, Delta Surgical, Evonos GmbH & Co. KG, Integra Lifescience Holding Corporation, Medtronic PLC, Microport Scientific Corporation, Mizuho Medical Incorporation, Spiegelberg, Stryker Corporation and Terumo Global (Microvention).

Get more information on this report : Request Sample Pages

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the intracranial aneurysm market analysis from 2021 to 2031 to identify the prevailing intracranial aneurysm market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the intracranial aneurysm market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global intracranial aneurysm market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

  • By Type
    • Surgical Clipping
    • Endovascular Coiling
    • Flow Diverters
    • Others
  • By End User
    • Hospitals
    • Clinics
    • Others
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • Rest of Europe
      • Germany
      • France
      • UK
      • Italy
      • Spain
    • Asia-Pacific
      • Japan
      • China
      • Australia
      • India
      • South Korea
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • Saudi Arabia
      • South Africa
      • Rest of LAMEA


Key Market Players

  • Delta Surgical
  • Terumo Global (Microvention)
  • B. Braun
  • Integra Life-science Holding Corporation
  • Medtronic PLC
  • Stryker Corporation
  • Evonos GmbH & Co. KG
  • Mizuho Medical Incorporation
  • Spiegelberg
  • Microport Scientific Corporation
  • CHAPTER 1:INTRODUCTION

    • 1.1.Report description

    • 1.2.Key market segments

    • 1.3.Key benefits to the stakeholders

    • 1.4.Research Methodology

      • 1.4.1.Secondary research

      • 1.4.2.Primary research

      • 1.4.3.Analyst tools and models

  • CHAPTER 2:EXECUTIVE SUMMARY

    • 2.1.Key findings of the study

    • 2.2.CXO Perspective

  • CHAPTER 3:MARKET OVERVIEW

    • 3.1.Market definition and scope

    • 3.2.Key findings

      • 3.2.1.Top investment pockets

    • 3.3.Porter’s five forces analysis

    • 3.4.Top player positioning

    • 3.5.Market dynamics

      • 3.5.1.Drivers

      • 3.5.2.Restraints

      • 3.5.3.Opportunities

    • 3.6.COVID-19 Impact Analysis on the market

  • CHAPTER 4: INTRACRANIAL ANEURYSM MARKET, BY TYPE

    • 4.1 Overview

      • 4.1.1 Market size and forecast

    • 4.2 Surgical Clipping

      • 4.2.1 Key market trends, growth factors and opportunities

      • 4.2.2 Market size and forecast, by region

      • 4.2.3 Market analysis by country

    • 4.3 Endovascular Coiling

      • 4.3.1 Key market trends, growth factors and opportunities

      • 4.3.2 Market size and forecast, by region

      • 4.3.3 Market analysis by country

    • 4.4 Flow Diverters

      • 4.4.1 Key market trends, growth factors and opportunities

      • 4.4.2 Market size and forecast, by region

      • 4.4.3 Market analysis by country

    • 4.5 Others

      • 4.5.1 Key market trends, growth factors and opportunities

      • 4.5.2 Market size and forecast, by region

      • 4.5.3 Market analysis by country

  • CHAPTER 5: INTRACRANIAL ANEURYSM MARKET, BY END USER

    • 5.1 Overview

      • 5.1.1 Market size and forecast

    • 5.2 Hospitals

      • 5.2.1 Key market trends, growth factors and opportunities

      • 5.2.2 Market size and forecast, by region

      • 5.2.3 Market analysis by country

    • 5.3 Clinics

      • 5.3.1 Key market trends, growth factors and opportunities

      • 5.3.2 Market size and forecast, by region

      • 5.3.3 Market analysis by country

    • 5.4 Others

      • 5.4.1 Key market trends, growth factors and opportunities

      • 5.4.2 Market size and forecast, by region

      • 5.4.3 Market analysis by country

  • CHAPTER 6: INTRACRANIAL ANEURYSM MARKET, BY REGION

    • 6.1 Overview

      • 6.1.1 Market size and forecast

    • 6.2 North America

      • 6.2.1 Key trends and opportunities

      • 6.2.2 North America Market size and forecast, by Type

      • 6.2.3 North America Market size and forecast, by End User

      • 6.2.4 North America Market size and forecast, by country

        • 6.2.4.1 U.S.
          • 6.2.4.1.1 Market size and forecast, by Type
          • 6.2.4.1.2 Market size and forecast, by End User
        • 6.2.4.2 Canada
          • 6.2.4.2.1 Market size and forecast, by Type
          • 6.2.4.2.2 Market size and forecast, by End User
        • 6.2.4.3 Mexico
          • 6.2.4.3.1 Market size and forecast, by Type
          • 6.2.4.3.2 Market size and forecast, by End User
    • 6.3 Europe

      • 6.3.1 Key trends and opportunities

      • 6.3.2 Europe Market size and forecast, by Type

      • 6.3.3 Europe Market size and forecast, by End User

      • 6.3.4 Europe Market size and forecast, by country

        • 6.3.4.1 Germany
          • 6.3.4.1.1 Market size and forecast, by Type
          • 6.3.4.1.2 Market size and forecast, by End User
        • 6.3.4.2 France
          • 6.3.4.2.1 Market size and forecast, by Type
          • 6.3.4.2.2 Market size and forecast, by End User
        • 6.3.4.3 UK
          • 6.3.4.3.1 Market size and forecast, by Type
          • 6.3.4.3.2 Market size and forecast, by End User
        • 6.3.4.4 Italy
          • 6.3.4.4.1 Market size and forecast, by Type
          • 6.3.4.4.2 Market size and forecast, by End User
        • 6.3.4.5 Spain
          • 6.3.4.5.1 Market size and forecast, by Type
          • 6.3.4.5.2 Market size and forecast, by End User
        • 6.3.4.6 Rest of Europe
          • 6.3.4.6.1 Market size and forecast, by Type
          • 6.3.4.6.2 Market size and forecast, by End User
    • 6.4 Asia-Pacific

      • 6.4.1 Key trends and opportunities

      • 6.4.2 Asia-Pacific Market size and forecast, by Type

      • 6.4.3 Asia-Pacific Market size and forecast, by End User

      • 6.4.4 Asia-Pacific Market size and forecast, by country

        • 6.4.4.1 Japan
          • 6.4.4.1.1 Market size and forecast, by Type
          • 6.4.4.1.2 Market size and forecast, by End User
        • 6.4.4.2 China
          • 6.4.4.2.1 Market size and forecast, by Type
          • 6.4.4.2.2 Market size and forecast, by End User
        • 6.4.4.3 Australia
          • 6.4.4.3.1 Market size and forecast, by Type
          • 6.4.4.3.2 Market size and forecast, by End User
        • 6.4.4.4 India
          • 6.4.4.4.1 Market size and forecast, by Type
          • 6.4.4.4.2 Market size and forecast, by End User
        • 6.4.4.5 South Korea
          • 6.4.4.5.1 Market size and forecast, by Type
          • 6.4.4.5.2 Market size and forecast, by End User
        • 6.4.4.6 Rest of Asia-Pacific
          • 6.4.4.6.1 Market size and forecast, by Type
          • 6.4.4.6.2 Market size and forecast, by End User
    • 6.5 LAMEA

      • 6.5.1 Key trends and opportunities

      • 6.5.2 LAMEA Market size and forecast, by Type

      • 6.5.3 LAMEA Market size and forecast, by End User

      • 6.5.4 LAMEA Market size and forecast, by country

        • 6.5.4.1 Brazil
          • 6.5.4.1.1 Market size and forecast, by Type
          • 6.5.4.1.2 Market size and forecast, by End User
        • 6.5.4.2 Saudi Arabia
          • 6.5.4.2.1 Market size and forecast, by Type
          • 6.5.4.2.2 Market size and forecast, by End User
        • 6.5.4.3 South Africa
          • 6.5.4.3.1 Market size and forecast, by Type
          • 6.5.4.3.2 Market size and forecast, by End User
        • 6.5.4.4 Rest of LAMEA
          • 6.5.4.4.1 Market size and forecast, by Type
          • 6.5.4.4.2 Market size and forecast, by End User
  • CHAPTER 7: COMPANY LANDSCAPE

    • 7.1. Introduction

    • 7.2. Top winning strategies

    • 7.3. Product Mapping of Top 10 Player

    • 7.4. Competitive Dashboard

    • 7.5. Competitive Heatmap

    • 7.6. Key developments

  • CHAPTER 8: COMPANY PROFILES

    • 8.1 B. Braun

      • 8.1.1 Company overview

      • 8.1.2 Company snapshot

      • 8.1.3 Operating business segments

      • 8.1.4 Product portfolio

      • 8.1.5 Business performance

      • 8.1.6 Key strategic moves and developments

    • 8.2 Delta Surgical

      • 8.2.1 Company overview

      • 8.2.2 Company snapshot

      • 8.2.3 Operating business segments

      • 8.2.4 Product portfolio

      • 8.2.5 Business performance

      • 8.2.6 Key strategic moves and developments

    • 8.3 Evonos GmbH & Co. KG

      • 8.3.1 Company overview

      • 8.3.2 Company snapshot

      • 8.3.3 Operating business segments

      • 8.3.4 Product portfolio

      • 8.3.5 Business performance

      • 8.3.6 Key strategic moves and developments

    • 8.4 Integra Life-science Holding Corporation

      • 8.4.1 Company overview

      • 8.4.2 Company snapshot

      • 8.4.3 Operating business segments

      • 8.4.4 Product portfolio

      • 8.4.5 Business performance

      • 8.4.6 Key strategic moves and developments

    • 8.5 Medtronic PLC

      • 8.5.1 Company overview

      • 8.5.2 Company snapshot

      • 8.5.3 Operating business segments

      • 8.5.4 Product portfolio

      • 8.5.5 Business performance

      • 8.5.6 Key strategic moves and developments

    • 8.6 Microport Scientific Corporation

      • 8.6.1 Company overview

      • 8.6.2 Company snapshot

      • 8.6.3 Operating business segments

      • 8.6.4 Product portfolio

      • 8.6.5 Business performance

      • 8.6.6 Key strategic moves and developments

    • 8.7 Mizuho Medical Incorporation

      • 8.7.1 Company overview

      • 8.7.2 Company snapshot

      • 8.7.3 Operating business segments

      • 8.7.4 Product portfolio

      • 8.7.5 Business performance

      • 8.7.6 Key strategic moves and developments

    • 8.8 Spiegelberg

      • 8.8.1 Company overview

      • 8.8.2 Company snapshot

      • 8.8.3 Operating business segments

      • 8.8.4 Product portfolio

      • 8.8.5 Business performance

      • 8.8.6 Key strategic moves and developments

    • 8.9 Stryker Corporation

      • 8.9.1 Company overview

      • 8.9.2 Company snapshot

      • 8.9.3 Operating business segments

      • 8.9.4 Product portfolio

      • 8.9.5 Business performance

      • 8.9.6 Key strategic moves and developments

    • 8.10 Terumo Global (Microvention)

      • 8.10.1 Company overview

      • 8.10.2 Company snapshot

      • 8.10.3 Operating business segments

      • 8.10.4 Product portfolio

      • 8.10.5 Business performance

      • 8.10.6 Key strategic moves and developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 2. INTRACRANIAL ANEURYSM MARKET, FOR SURGICAL CLIPPING, BY REGION, 2021-2031 ($MILLION)
    TABLE 3. INTRACRANIAL ANEURYSM MARKET FOR SURGICAL CLIPPING, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 4. INTRACRANIAL ANEURYSM MARKET, FOR ENDOVASCULAR COILING, BY REGION, 2021-2031 ($MILLION)
    TABLE 5. INTRACRANIAL ANEURYSM MARKET FOR ENDOVASCULAR COILING, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 6. INTRACRANIAL ANEURYSM MARKET, FOR FLOW DIVERTERS, BY REGION, 2021-2031 ($MILLION)
    TABLE 7. INTRACRANIAL ANEURYSM MARKET FOR FLOW DIVERTERS, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 8. INTRACRANIAL ANEURYSM MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
    TABLE 9. INTRACRANIAL ANEURYSM MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 10. GLOBAL INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 11. INTRACRANIAL ANEURYSM MARKET, FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
    TABLE 12. INTRACRANIAL ANEURYSM MARKET FOR HOSPITALS, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 13. INTRACRANIAL ANEURYSM MARKET, FOR CLINICS, BY REGION, 2021-2031 ($MILLION)
    TABLE 14. INTRACRANIAL ANEURYSM MARKET FOR CLINICS, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 15. INTRACRANIAL ANEURYSM MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
    TABLE 16. INTRACRANIAL ANEURYSM MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 17. INTRACRANIAL ANEURYSM MARKET, BY REGION, 2021-2031 ($MILLION)
    TABLE 18. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 19. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 20. NORTH AMERICA INTRACRANIAL ANEURYSM MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 21. U.S. INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 22. U.S. INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 23. CANADA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 24. CANADA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 25. MEXICO INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 26. MEXICO INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 27. EUROPE INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 28. EUROPE INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 29. EUROPE INTRACRANIAL ANEURYSM MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 30. GERMANY INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 31. GERMANY INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 32. FRANCE INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 33. FRANCE INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 34. UK INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 35. UK INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 36. ITALY INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 37. ITALY INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 38. SPAIN INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 39. SPAIN INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 40. REST OF EUROPE INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 41. REST OF EUROPE INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 42. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 43. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 44. ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 45. JAPAN INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 46. JAPAN INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 47. CHINA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 48. CHINA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 49. AUSTRALIA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 50. AUSTRALIA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 51. INDIA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 52. INDIA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 53. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 54. SOUTH KOREA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 55. REST OF ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 56. REST OF ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 57. LAMEA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 58. LAMEA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 59. LAMEA INTRACRANIAL ANEURYSM MARKET, BY COUNTRY, 2021-2031 ($MILLION)
    TABLE 60. BRAZIL INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 61. BRAZIL INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 62. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 63. SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 64. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 65. SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 66. REST OF LAMEA INTRACRANIAL ANEURYSM MARKET, BY TYPE, 2021-2031 ($MILLION)
    TABLE 67. REST OF LAMEA INTRACRANIAL ANEURYSM MARKET, BY END USER, 2021-2031 ($MILLION)
    TABLE 68.B. BRAUN: COMPANY SNAPSHOT
    TABLE 69.B. BRAUN: OPERATING SEGMENTS
    TABLE 70.B. BRAUN: PRODUCT PORTFOLIO
    TABLE 71.B. BRAUN: NET SALES,
    TABLE 72.B. BRAUN: KEY STRATERGIES
    TABLE 73.DELTA SURGICAL: COMPANY SNAPSHOT
    TABLE 74.DELTA SURGICAL: OPERATING SEGMENTS
    TABLE 75.DELTA SURGICAL: PRODUCT PORTFOLIO
    TABLE 76.DELTA SURGICAL: NET SALES,
    TABLE 77.DELTA SURGICAL: KEY STRATERGIES
    TABLE 78.EVONOS GMBH & CO. KG: COMPANY SNAPSHOT
    TABLE 79.EVONOS GMBH & CO. KG: OPERATING SEGMENTS
    TABLE 80.EVONOS GMBH & CO. KG: PRODUCT PORTFOLIO
    TABLE 81.EVONOS GMBH & CO. KG: NET SALES,
    TABLE 82.EVONOS GMBH & CO. KG: KEY STRATERGIES
    TABLE 83.INTEGRA LIFE-SCIENCE HOLDING CORPORATION: COMPANY SNAPSHOT
    TABLE 84.INTEGRA LIFE-SCIENCE HOLDING CORPORATION: OPERATING SEGMENTS
    TABLE 85.INTEGRA LIFE-SCIENCE HOLDING CORPORATION: PRODUCT PORTFOLIO
    TABLE 86.INTEGRA LIFE-SCIENCE HOLDING CORPORATION: NET SALES,
    TABLE 87.INTEGRA LIFE-SCIENCE HOLDING CORPORATION: KEY STRATERGIES
    TABLE 88.MEDTRONIC PLC: COMPANY SNAPSHOT
    TABLE 89.MEDTRONIC PLC: OPERATING SEGMENTS
    TABLE 90.MEDTRONIC PLC: PRODUCT PORTFOLIO
    TABLE 91.MEDTRONIC PLC: NET SALES,
    TABLE 92.MEDTRONIC PLC: KEY STRATERGIES
    TABLE 93.MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
    TABLE 94.MICROPORT SCIENTIFIC CORPORATION: OPERATING SEGMENTS
    TABLE 95.MICROPORT SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
    TABLE 96.MICROPORT SCIENTIFIC CORPORATION: NET SALES,
    TABLE 97.MICROPORT SCIENTIFIC CORPORATION: KEY STRATERGIES
    TABLE 98.MIZUHO MEDICAL INCORPORATION: COMPANY SNAPSHOT
    TABLE 99.MIZUHO MEDICAL INCORPORATION: OPERATING SEGMENTS
    TABLE 100.MIZUHO MEDICAL INCORPORATION: PRODUCT PORTFOLIO
    TABLE 101.MIZUHO MEDICAL INCORPORATION: NET SALES,
    TABLE 102.MIZUHO MEDICAL INCORPORATION: KEY STRATERGIES
    TABLE 103.SPIEGELBERG: COMPANY SNAPSHOT
    TABLE 104.SPIEGELBERG: OPERATING SEGMENTS
    TABLE 105.SPIEGELBERG: PRODUCT PORTFOLIO
    TABLE 106.SPIEGELBERG: NET SALES,
    TABLE 107.SPIEGELBERG: KEY STRATERGIES
    TABLE 108.STRYKER CORPORATION: COMPANY SNAPSHOT
    TABLE 109.STRYKER CORPORATION: OPERATING SEGMENTS
    TABLE 110.STRYKER CORPORATION: PRODUCT PORTFOLIO
    TABLE 111.STRYKER CORPORATION: NET SALES,
    TABLE 112.STRYKER CORPORATION: KEY STRATERGIES
    TABLE 113.TERUMO GLOBAL (MICROVENTION): COMPANY SNAPSHOT
    TABLE 114.TERUMO GLOBAL (MICROVENTION): OPERATING SEGMENTS
    TABLE 115.TERUMO GLOBAL (MICROVENTION): PRODUCT PORTFOLIO
    TABLE 116.TERUMO GLOBAL (MICROVENTION): NET SALES,
    TABLE 117.TERUMO GLOBAL (MICROVENTION): KEY STRATERGIES
  • LIST OF FIGURES

  • FIGURE 1.INTRACRANIAL ANEURYSM MARKET SEGMENTATION
    FIGURE 2.INTRACRANIAL ANEURYSM MARKET,2021-2031
    FIGURE 3.INTRACRANIAL ANEURYSM MARKET,2021-2031
    FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
    FIGURE 5.PORTER FIVE-1
    FIGURE 6.PORTER FIVE-2
    FIGURE 7.PORTER FIVE-3
    FIGURE 8.PORTER FIVE-4
    FIGURE 9.PORTER FIVE-5
    FIGURE 10.TOP PLAYER POSITIONING
    FIGURE 11.INTRACRANIAL ANEURYSM MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
    FIGURE 12.INTRACRANIAL ANEURYSM MARKET,BY TYPE,2021(%)
    FIGURE 13.COMPARATIVE SHARE ANALYSIS OF SURGICAL CLIPPING INTRACRANIAL ANEURYSM MARKET,2021-2031(%)
    FIGURE 14.COMPARATIVE SHARE ANALYSIS OF ENDOVASCULAR COILING INTRACRANIAL ANEURYSM MARKET,2021-2031(%)
    FIGURE 15.COMPARATIVE SHARE ANALYSIS OF FLOW DIVERTERS INTRACRANIAL ANEURYSM MARKET,2021-2031(%)
    FIGURE 16.COMPARATIVE SHARE ANALYSIS OF OTHERS INTRACRANIAL ANEURYSM MARKET,2021-2031(%)
    FIGURE 17.INTRACRANIAL ANEURYSM MARKET,BY END USER,2021(%)
    FIGURE 18.COMPARATIVE SHARE ANALYSIS OF HOSPITALS INTRACRANIAL ANEURYSM MARKET,2021-2031(%)
    FIGURE 19.COMPARATIVE SHARE ANALYSIS OF CLINICS INTRACRANIAL ANEURYSM MARKET,2021-2031(%)
    FIGURE 20.COMPARATIVE SHARE ANALYSIS OF OTHERS INTRACRANIAL ANEURYSM MARKET,2021-2031(%)
    FIGURE 21.INTRACRANIAL ANEURYSM MARKET BY REGION,2021
    FIGURE 22.U.S. INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
    FIGURE 23.CANADA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
    FIGURE 24.MEXICO INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
    FIGURE 25.GERMANY INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
    FIGURE 26.FRANCE INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
    FIGURE 27.UK INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
    FIGURE 28.ITALY INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
    FIGURE 29.SPAIN INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
    FIGURE 30.REST OF EUROPE INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
    FIGURE 31.JAPAN INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
    FIGURE 32.CHINA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
    FIGURE 33.AUSTRALIA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
    FIGURE 34.INDIA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
    FIGURE 35.SOUTH KOREA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
    FIGURE 36.REST OF ASIA-PACIFIC INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
    FIGURE 37.BRAZIL INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
    FIGURE 38.SAUDI ARABIA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
    FIGURE 39.SOUTH AFRICA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
    FIGURE 40.REST OF LAMEA INTRACRANIAL ANEURYSM MARKET,2021-2031($MILLION)
    FIGURE 41. TOP WINNING STRATEGIES, BY YEAR
    FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT
    FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY
    FIGURE 44.PRODUCT MAPPING OF TOP 10 PLAYERS
    FIGURE 45.COMPETITIVE DASHBOARD
    FIGURE 46.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
    FIGURE 47.B. BRAUN.: NET SALES ,($MILLION)
    FIGURE 48.DELTA SURGICAL.: NET SALES ,($MILLION)
    FIGURE 49.EVONOS GMBH & CO. KG.: NET SALES ,($MILLION)
    FIGURE 50.INTEGRA LIFE-SCIENCE HOLDING CORPORATION.: NET SALES ,($MILLION)
    FIGURE 51.MEDTRONIC PLC.: NET SALES ,($MILLION)
    FIGURE 52.MICROPORT SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
    FIGURE 53.MIZUHO MEDICAL INCORPORATION.: NET SALES ,($MILLION)
    FIGURE 54.SPIEGELBERG.: NET SALES ,($MILLION)
    FIGURE 55.STRYKER CORPORATION.: NET SALES ,($MILLION)
    FIGURE 56.TERUMO GLOBAL (MICROVENTION).: NET SALES ,($MILLION)

Purchase Full Report of
Intracranial Aneurysm Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue